Letter: Are Sorafenib-Related Adverse Events Associated With Prolonged Survival? Authors' Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15572
Full Text
Open PDFAbstract
Available in full text
Date
December 18, 2019
Authors
Publisher
Wiley